Abstract
The pharmacokinetics of isoniazid (INH) was studied in children (0-196 months old) according to their acetylator phenotype, estimated from the metabolic acetyl INH/INH molar plasma concentration ratio (MR) measured 3 h after INH oral administration. There were 17 slow (MR < 0.48) and 17 fast acetylators (MR > or = 0.48). The mean apparent plasma clearance was significantly lower, the mean apparent volume of distribution higher and the half-life longer in the slow acetylator group (C1, 0.298 +/- 0.099 L/h/kg; Vd, 1.56 +/- 0.65 L/kg; t1/2, 3.88 +/- 01.89 h) than in the fast acetylator group (Cl, 0.528 +/- 0.234 L/h/kg; Vd, 1.06 +/- 0.45; t1/2, 1.64 +/- 1.1 h). The half-life decreased with age. An impaired isoniazid elimination was suggested in children less than three months old, which may be in favour of an individual dose adjustment in this population.
References
Nov 1, 1979·Clinical Pharmacokinetics·W W Weber, D W Hein
Jan 1, 1986·European Journal of Clinical Pharmacology·M F KerguerisC Larousse
Aug 1, 1980·British Journal of Clinical Pharmacology·C AdvenierJ P Tillement
Dec 1, 1993·Clinical Pharmacology and Therapeutics·Y G KimY N Cha
Nov 14, 1997·Clinical Pharmacology and Therapeutics·A Pariente-KhayatG Pons
Mar 5, 1998·Therapeutic Drug Monitoring·E ReyD Gendrel
Oct 21, 1998·Therapeutic Drug Monitoring·W W Yew
Sep 25, 1999·Clinical Pharmacokinetics·J G Douglas, M J McLeod
Citations
Jun 15, 2012·Therapeutic Drug Monitoring·Jennifer J KiserCourtney V Fletcher
Nov 26, 2010·Antimicrobial Agents and Chemotherapy·Prakash M JeenaTawanda Gumbo
Oct 5, 2011·Antimicrobial Agents and Chemotherapy·S TheeH S Schaaf
May 24, 2005·Archives of Disease in Childhood·H S SchaafP R Donald
Feb 19, 2014·Pharmacogenomics·Lilly M VerhagenRob E Aarnoutse
Apr 7, 2012·Clinical Radiology·Z I HasilogluN Kocer
Mar 1, 2012·The Lancet Infectious Diseases·James A SeddonH Simon Schaaf
Feb 5, 2008·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Michael HawkesDat Tran
May 30, 2009·Pharmacotherapy·Gail D Anderson, Anne M Lynn
Oct 10, 2008·Clinical Pharmacology and Therapeutics·M J KennedyG L Kearns
May 12, 2011·Journal of Clinical Pharmacology·Rui ZhuCourtney V Fletcher
Nov 9, 2004·Preventive Medicine·C R MacintyreG V Brown
Apr 4, 2016·BMC Infectious Diseases·Thomas PouplinJeremy N Day
Aug 17, 2016·EBioMedicine·Zoe RogersTawanda Gumbo
Feb 5, 2014·Antimicrobial Agents and Chemotherapy·A BekkerA C Hesseling
Sep 11, 2007·Biopharmaceutics & Drug Disposition·Helen M BaldanRosângela G P Machado
Dec 2, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Peter BuchwaldNicholas Bodor
Feb 7, 2019·Frontiers in Pharmacology·Estella Dora Germaine GaressusUrsula Gundert-Remy
Mar 28, 2019·Indian Journal of Pediatrics·Aparna MukherjeeS K Kabra
Nov 4, 2020·Antimicrobial Agents and Chemotherapy·Navarat PanjasawatwongJoel Tarning